Fund Holdings — Altium Capital Management LLC

Total Portfolio Value:
$0
Total Bought:
$0
Total Sold:
$34.43M
Net Transaction:
-$34.43M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
NoneNONE000$0$0—$0
Alpha Cognition Inc. Common Stock(ACOG)177,4160-177,416$897.7K$0—-$897.7K
Anteris Technologies Global Corp.(AVR)168,5890-168,589$613.7K$0—-$613.7K
Avadel Pharmaceuticals Plc419,1310-419,131$3.28M$0—-$3.28M
SRX Global Inc.(SRXH)38,9840-38,984$67.1K$0—-$67.1K
Contineum Therapeutics, Inc.CL A(CTNM)303,8570-303,857$2.12M$0—-$2.12M
enVVeno Medical Corporation(NVNO)123,2560-123,256$324.2K$0—-$324.2K
Essa Pharma Inc1,050,3690-1,050,369$1.66M$0—-$1.66M
Evolus, Inc.(EOLS)296,1930-296,193$3.56M$0—-$3.56M
Intelligent Bio Solutions In149,2520-149,252$214.9K$0—-$214.9K
Karyopharm Therapeutics Inc.(KPTI)49,3330-49,333$184.5K$0—-$184.5K
Larimar Therapeutics, Inc.(LRMR)273,2040-273,204$587.4K$0—-$587.4K
Logicmark Inc5,395,3080-5,395,308$106.8K$0—-$106.8K
Nektar Therapeutics(NKTR)1,051,3790-1,051,379$714.9K$0—-$714.9K
Profound Medical Corp.(PROF)360,5890-360,589$2.10M$0—-$2.10M
Promis Neurosciences Inc574,2480-574,248$399.4K$0—-$399.4K
Rezolute, Inc.(RZLT)303,9490-303,949$881.5K$0—-$881.5K
Sharps Technology Inc4,044,1490-4,044,149$110.4K$0—-$110.4K
Skye Bioscience, Inc.(SKYE)904,8650-904,865$1.44M$0—-$1.44M
Sunshine Biopharma, Inc.(SBFM)50,4660-50,466$96.4K$0—-$96.4K
Xenon Pharmaceuticals Inc.(XENE)60,2510-60,251$2.02M$0—-$2.02M
Xtant Medical Holdings, Inc.(XTNT)7,252,9980-7,252,998$3.41M$0—-$3.41M
Zevra Therapeutics, Inc.(ZVRA)1,287,3330-1,287,333$9.64M$0—-$9.64M
Page 1 of 1
Altium Capital Management LLC — 13F Holdings — Q2 2025 | TickerTrail